AVBP
ArriVent BioPharma, Inc. Common Stock
NASDAQ: AVBP · HEALTHCARE · BIOTECHNOLOGY
$31.09
+3.46% today
Updated 2026-04-30
Market cap
$1.34B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.32
Dividend yield
—
52W range
$16 – $32
Volume
0.5M
ArriVent BioPharma, Inc. Common Stock (AVBP) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | $43.04M | $182.83M | $163.10M | $274.94M |
| Cash & equivalents | $37.28M | $163.37M | $150.39M | $74.29M |
| Current assets | $42.95M | $182.62M | $159.97M | $226.98M |
| Total liabilities | $1.82M | $8.37M | $11.80M | $17.29M |
| Current liabilities | $1.82M | $8.36M | $11.62M | $17.27M |
| Long-term debt | — | — | — | — |
| Shareholder equity | $41.22M | $174.46M | $151.30M | $257.65M |
| Retained earnings | $-51.61M | $-88.51M | $-157.84M | $-238.33M |
| Accounts receivable | $250000.00 | $500000.00 | $761000.00 | $500000.00 |
| Inventory | — | — | $-240000.00 | — |
| Goodwill | — | — | — | — |